On an average, around 50 drugs are approved by the US Food and Drug Administration (US FDA) annually. Further, studies indicate that more than 100,000 tons of pharmaceutical products are consumed globally per year. In addition, over the next five years, the global pharmaceutical market is projected to grow at a CAGR of 4.7%, with global drug sales anticipated to raise revenues worth USD 1.5 trillion in 2023. This continuously growing pipeline of pharmaceutical drug products has inadvertently led to an increase in the demand for their associated primary packaging and secondary packaging solutions. Specifically, pharmaceutical secondary packaging is a vital step in the product supply chain as it encloses life-saving drugs and therapies, preserving the identity, quality, integrity and stability of the packaged drug product. It also plays a key role in marketing and brand projection for a product. However, the process of secondary packaging usually involves time consuming and complex activities, such as blister carding, thermoforming, labeling, kitting, assembly and cold chain storage (for temperature sensitive biologics). Other key challenges faced by developers are limiting variability in packaging materials and ensuring compliance to stringent regulatory guidelines (for packaging designs). Considering the aforementioned concerns, many pharmaceutical players now prefer to collaborate with qualified packaging providers that offer non-traditional packaging solutions and have the required capabilities to create unique packaging designs, in a cost and time effective manner.
As per the CDMO Outsourcing Survey conducted by Nice Insight, specifically for clinical and commercial scale operations, nearly 60% of the pharmaceutical companies currently outsource their primary packaging needs, while 43% of the players outsource their secondary packaging requirements. At present, more than 160 companies offer secondary packaging solutions to the firms engaged in the pharmaceutical sector. Further, several recent advancements in packaging designs, technologies and materials have enabled service providers to offer a wide range of user-friendly pharmaceutical secondary packaging solutions. In addition, substantial expansions, mergers and acquisitions, and partnerships have been reported in this market as service providers strive to become one-stop-shops, in order to cater to the diverse needs of their clients engaged in the healthcare industry. Driven by the ongoing innovation in this field, continuous growth in the pharmaceutical drugs pipeline and a steady rise in drug approvals, the pharmaceutical secondary packaging market is likely to witness positive growth in the foreseen future.
The ‘Pharmaceutical Secondary Packaging Market - Distribution by Type of Secondary Packaging (Boxes, Cartons and Pouches), Type of Primary Packaging Packed (Ampoules, Blister Packs, Bottles, Cartridges, Syringes and Vials) and Key Geographies (North America, Europe, Asia-Pacific, MENA, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035’ report features an extensive study of the current market landscape and future potential of the pharmaceutical secondary packaging market. The study features an in-depth analysis, highlighting the capabilities of pharmaceutical secondary packaging providers.
As per the CDMO Outsourcing Survey conducted by Nice Insight, specifically for clinical and commercial scale operations, nearly 60% of the pharmaceutical companies currently outsource their primary packaging needs, while 43% of the players outsource their secondary packaging requirements. At present, more than 160 companies offer secondary packaging solutions to the firms engaged in the pharmaceutical sector. Further, several recent advancements in packaging designs, technologies and materials have enabled service providers to offer a wide range of user-friendly pharmaceutical secondary packaging solutions. In addition, substantial expansions, mergers and acquisitions, and partnerships have been reported in this market as service providers strive to become one-stop-shops, in order to cater to the diverse needs of their clients engaged in the healthcare industry. Driven by the ongoing innovation in this field, continuous growth in the pharmaceutical drugs pipeline and a steady rise in drug approvals, the pharmaceutical secondary packaging market is likely to witness positive growth in the foreseen future.
Scope of the Report
The ‘Pharmaceutical Secondary Packaging Market - Distribution by Type of Secondary Packaging (Boxes, Cartons and Pouches), Type of Primary Packaging Packed (Ampoules, Blister Packs, Bottles, Cartridges, Syringes and Vials) and Key Geographies (North America, Europe, Asia-Pacific, MENA, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035’ report features an extensive study of the current market landscape and future potential of the pharmaceutical secondary packaging market. The study features an in-depth analysis, highlighting the capabilities of pharmaceutical secondary packaging providers.
Amongst other elements, the report features:
- A detailed overview of the overall landscape of companies offering secondary packaging solutions to the pharmaceutical and biotechnology industries, along with information on several relevant parameters, such as their year of establishment, company size (in terms of employee count), location of headquarters (North America, Europe, Asia-Pacific and rest of the world) and scale of operation (preclinical, clinical and commercial). The chapter also covers details related to the type of service provider (one-stop-shop service providers and stand-alone service providers), type of secondary packaging offered (cartons, boxes and others), type of primary packaging packed (blisters, vials, bottles, conventional syringes, ampoules, prefilled syringes and others), type of molecule packed (biologics, small molecules and unspecified), type of finished dosage form packed (solids, liquids/injectables, semi-solids, powders and others) and type of additional service(s) offered (labeling, serialization, kitting and cold-chain storage).
- An insightful competitiveness analysis of the pharmaceutical secondary packaging providers, based on supplier power (in terms of years of experience), company competitiveness (type secondary packaging offered, type of primary packaging packed, type of molecule packed, type of finished dosage form packed, and type of additional services offered) and their respective scale of operation.
- An analysis of recent partnerships inked between stakeholders engaged in this domain, during the period 2018-2021, covering acquisitions, manufacturing and packaging agreements, service alliances, packaging agreements, distribution agreements, technology utilization agreements and other related agreements. Further, the partnership activity in this domain has been analyzed based on various parameters, such as year of partnership, type of partnership, type of molecule packed, type of finished dosage form packed and most active players (in terms of number of partnerships). It also highlights the regional distribution of the partnership activity witnessed in this market.
- A detailed analysis of the recent expansions undertaken by various pharmaceutical secondary packaging providers, based on several relevant parameters, such as year of expansion, type of expansion (capacity expansion, facility expansion and new facility), scale of operation, type of primary packaging packed, type of molecule packed, type of finished dosage form packed, company size, location of headquarters, location of expanded facility, most active players (in terms of number of recent expansions) and geographical distribution (region-wise and country-wise).
- An in-depth analysis to estimate the current and future demand for pharmaceutical secondary packaging, based on several relevant parameters, such as type of secondary packaging (boxes, cartons and pouches), type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world), for the period 2022-2035.
- Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in offering pharmaceutical secondary packaging solutions, across North America, Europe and Asia-Pacific. Each profile provides an overview of the company, featuring information on the year of establishment, number of employees, location of their headquarters, key executives, details related to its secondary packaging offerings, recent developments, and an informed future outlook
- One of the key objectives of the report was to evaluate the current opportunity and future potential associated with the pharmaceutical secondary packaging market, over the coming 13 years. We have provided an informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as [A] type of secondary packaging (boxes, cartons and others), [B] type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and [C] key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world). To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
The report features detailed transcripts of interviews held with the following individuals:
- Jake Aspinall (Commercial Director, Active Pharma Supplies)
- Silvio Del Deo (Managing Director, Depo Pack)
- Joe Luke (Vice President, Sales and Marketing, Reed-Lane)
Key Questions Answered
- Who are the leading players engaged in the pharmaceutical secondary packaging domain?
- What is the relative competitiveness of different pharmaceutical secondary packaging providers?
- Which type of partnership models are most commonly adopted by industry stakeholders?
- What kind of expansion initiatives have been undertaken by pharmaceutical secondary packaging providers?
- What is the present and likely future demand for secondary packaging solutions in the pharmaceutical sector?
- How is the current and future market opportunity likely to be distributed across key market segments?
Table of Contents
1. PREFACE
3. INTRODUCTION
4. COMPETITIVE LANDSCAPE
5. COMPANY COMPETITIVENESS ANALYSIS
6. COMPANY PROFILES: PHARMACEUTICAL SECONDARY PACKAGING PROVIDERS IN NORTH AMERICA
7. COMPANY PROFILES: PHARMACEUTICAL SECONDARY PACKAGING PROVIDERS IN EUROPE
8. COMPANY PROFILES: PHARMACEUTICAL SECONDARY PACKAGING PROVIDERS IN ASIA-PACIFIC
9. PARTNERSHIPS AND COLLABORATIONS
10. RECENT EXPANSIONS
11. DEMAND ANALYSIS
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
14. EXECUTIVE INSIGHTS
List Of Figures
List Of Tables
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3C! Packaging
- 3R Pharmaceutical Industries
- ABS (Australian Blister Sealing)
- Acceleration Laboratory Services
- Acorda Therapeutics
- Active Pharma Supplies
- Aenova
- Alcami
- Alcura
- Alifarm Laboratories
- allpack group
- Almac Group
- Alnylam Pharmaceuticals
- Amcor
- Amgen
- Ansapack
- Anthos Therapeutics
- Aphena Pharma Solutions
- Aquapak
- AR Packaging
- Ardena
- Arkay Packaging
- AstraZeneca
- Atecna
- Aucta Pharmaceuticals
- Autajon
- BAP Pharma
- Bellwyck
- Bellwyck Pharma Services (acquired by PCI Pharma Services)
- Bemis
- Berkshire Sterile Manufacturing
- Berlin Packaging
- Berry Global
- Biotechnica (acquired by Central Pharma)
- Birchwood Contract Manufacturing
- Bormioli Pharma
- Bristol-Myers Squibb
- Bushu Pharma
- Caligor Coghlan Pharma Services
- Cannasupplies
- Capsugel
- Cardinal Health
- Carton Service
- Catalent
- CCL Healthcare
- CellBios
- Central Pharma
- CIT
- CleanCut Technologies (acquired by Oliver Healthcare Packaging)
- CMIC Group
- Cobra Biologics
- Constantia Flexibles
- Content Group
- CordenPharma
- CoreRx
- Corplex
- Coveris
- CREAPHARM
- CRNA Pharma
- CRYOPDP
- Cryoport Systems
- CWS Contract Packaging
- Dec Group
- Depo Pack
- Dr. Müller Pharma
- DS Smith
- Dunamis Packaging
- East Pharma Technologies
- Ecobliss
- elpack
- Endeavour Foundation
- Essentra Packaging
- Eumedica
- Eurofins CDMO
- EVERSANA
- Experic
- Faller Packaging
- Falorni Pharma
- Fermion (subsidiary of Orion)
- FIDELIO Healthcare
- First Wave BioPharma
- Firstan Holdings (acquired by AR Packaging)
- G&W Laboratories
- GCL Pharma
- GHO Capital
- Global Pharma CM
- good natured
- Graphic Packaging International
- HENNIG ARZNEIMITTEL
- HERMES PHARMA
- Honeywood (acquired by Wasdell Group)
- Howell Packaging
- Hughes Enterprises
- Huhtamaki
- IMP Pharmaceutical Services
- Inno4Life (acquired by Dec Group)
- Innova Medical Group
- Intrapak
- IRISYS (acquired by Recro)
- Janssen
- Jones Healthcare Group
- K+D (acquired by AR Packaging)
- Kansas City Design (acquired by Oliver Healthcare Packaging)
- KapStone (acquired by WestRock)
- Kerry Pharma
- Keystone Folding Box
- KFM Co-Packer
- KISHORE GROUP
- Klocke Group
- Klocke of America
- Konsyl Pharmaceuticals
- Körber Pharma
- Koru Pacific Packaging
- Kroha (acquired by AR packaging)
- Kymanox
- Leca Graphics
- Legacy Pharma Solutions
- Linkx Packaging Systems (acquired by WestRock)
- Lonza
- LSNE Contract Manufacturing
- Lutz Packaging
- Mak Pharma
- Manufacture Générale de Joints (MGJ)
- McKesson RxPak
- MED PACK
- Med-X-Press
- Mikart (acquired by Nautic Partners)
- Mission Pharmacal
- MM Packaging
- Moderna
- Mondi Group
- Morgen Pharmaceutical Services (MPhS)
- Nautic Partners
- Nedupack Thermoforming
- Network Partners
- NUVISAN
- Oliver Healthcare Packaging
- Omaks Printing and Packaging
- oncomed
- Origin Pharma Packaging
- Orlando-Equity
- Orofino Pharmaceuticals
- PACS International
- Palladio Group
- Pangraph
- PaperFoam
- Paperpack
- Paras Printpack
- Parle Global Technologies
- Patheon (Thermo Fischer Scientific)
- PCI Pharma Services
- Pelican BioThermal
- Pemcor Packaging
- Performance Systematix (acquired by Selig Group)
- Pfizer CentreOne
- Pharma Packaging Solutions (acquired by Tjoapack)
- Pharma Print (acquired by Faller Packaging)
- Pharmaceutical Contractors
- Pharmaceutical Packaging Professionals (acquired by PCI Pharma Services)
- Pharmaserv Logistics
- Pharmasol
- Pharmeco
- Phathom Pharmaceuticals
- Photocure
- Piramal Pharma Solutions
- PKG Packaging
- Planned Packaging Films (acquired by Wasdell Group)
- Plymouth Packaging (acquired by WestRock)
- Praxis Packaging Solutions
- Prespack
- Prince Art Packages
- Qualiskills
- Quality Chemicals
- Quality Packaging Specialists International (QPSI)
- Quinta-Analytica
- Recipharm
- Recro
- Reed-Lane
- RENOLIT Healthcare
- REPASSA
- rlc Packaging Group (acquired by AR Packaging)
- Rondo-Pak
- Ropack Pharma Solutions
- Salus Group
- SANTA Pharm
- Santen Pharmaceutical
- Schluter Print Pharma Packaging (acquired by WestRock)
- SCHOTT
- Selig Flexibles
- Sentry BioPharma Services
- Sepha
- Seveillar Clinical Supplies
- SGD Pharma
- Sharp
- Sherpa Clinical Packaging (acquired by PCI Pharma Services)
- Singota Solutions
- SkyePharma
- Smurfit Kappa
- Sonoco
- Spectrum Pharma
- SteriPack
- Stevanato Group
- Supply Chain Wizard
- Suzuken
- Swiftpak
- SYNERLAB Group
- Syntegon
- Takeda Pharmaceutical
- Tapemark
- Tenco Assemblies
- Teva-Takeda Pharmaceuticals
- The FlexPro Group
- Therabel
- Tjoapack
- Total Health Centre
- TriRx Pharmaceutical Services
- TT-print (acquired by Constantia Flexibles)
- Unette
- Unither Pharmaceuticals
- Veratrak
- Verpak Ambalaj
- Vetter Pharma
- Vihaa Print And Pack
- Voigt Industrie Service
- Wasdell Group
- West Pharmaceutical Services
- WestRock
- Wuxi Griffin
- Xellia Pharmaceuticals
- Xerimis
- Yourway
Methodology
LOADING...